Drug ID: | NPD7558 |
Drug Name: | LY-377604 |
Molecular Formula: | C31H32N4O4 |
Canonical SMILES: | O[C@@H](CNC(Cc1ccc(cc1)Oc1ccc(cn1)C(=N)O)(C)C)COc1cccc2c1c1ccccc1[nH]2 |
Standard InCHI: | InChI=1S/C31H32N4O4/c1-31(2,16-20-10-13-23(14-11-20)39-28-15-12-21(17-33-28)30(32)37)34-18-22(36)19-38-27-9-5-8-26-29(27)24-6-3-4-7-25(24)35-26/h3-15,17,22,34-36H,16,18-19H2,1-2H3,(H2,32,37)/t22-/m0/s1 |
Standard InCHIKey: | RBSGUQYXRDKPAE-QFIPXVFZSA-N |
Max Developmental Stage: | Phase 2 |
Max Developmental Stage Source: | ChEMBL |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB003999 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 524.24 |
ALogP | -0.8028 |
MLogP | 3.99 |
XLogP | 6.51 |
HDA | 6 |
HBD | 5 |
Rotatable Bonds | 15 |
TPSA | 123.48 |
RO5 Violation | 2 |